<VariationArchive VariationID="55817" VariationName="NM_001278689.2(EOGT):c.1074del (p.Gly359fs)" VariationType="Deletion" Accession="VCV000055817" Version="29" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-07-15" DateCreated="2015-03-12" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="70473" VariationID="55817">
      <GeneList>
        <Gene Symbol="EOGT" FullName="EGF domain specific O-linked N-acetylglucosamine transferase" GeneID="285203" HGNC_ID="HGNC:28526" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="68975225" stop="69013684" display_start="68975225" display_stop="69013684" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="69024367" stop="69062773" display_start="69024367" display_stop="69062773" Strand="-" />
          </Location>
          <OMIM>614789</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001278689.2(EOGT):c.1074del (p.Gly359fs)</Name>
      <CanonicalSPDI>NC_000003.12:68988303:TT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p14.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="68988304" stop="68988304" display_start="68988304" display_stop="68988304" variantLength="1" positionVCF="68988303" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="69037455" stop="69037455" display_start="69037455" display_stop="69037455" variantLength="1" positionVCF="69037454" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>G359fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.69037456del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.69037456del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.68988305del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.68988305del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042829.1" sequenceAccession="NG_042829" sequenceVersion="1" change="g.30591del">
            <Expression>NG_042829.1:g.30591del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278689.2" sequenceAccession="NM_001278689" sequenceVersion="2" change="c.1074del" MANESelect="true">
            <Expression>NM_001278689.2:c.1074del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001265618.1" sequenceAccession="NP_001265618" sequenceVersion="1" change="p.Gly359fs">
            <Expression>NP_001265618.1:p.Gly359fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_103826.2" sequenceAccession="NR_103826" sequenceVersion="2" change="n.1329del">
            <Expression>NR_103826.2:n.1329del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_173654.3" sequenceAccession="NM_173654" sequenceVersion="3" change="c.832-791del">
            <Expression>NM_173654.3:c.832-791del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278689.1" sequenceAccession="NM_001278689" sequenceVersion="1" change="c.1074delA">
            <Expression>NM_001278689.1:c.1074delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA214430" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="614789.0002" DB="OMIM" />
        <XRef Type="rs" ID="587776994" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001278689.2(EOGT):c.1074del (p.Gly359fs) AND Adams-Oliver syndrome 4" Accession="RCV000049242" Version="9">
        <ClassifiedConditionList TraitSetID="10612">
          <ClassifiedCondition DB="MedGen" ID="C3809092">Adams-Oliver syndrome 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-04-04" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001278689.2(EOGT):c.1074del (p.Gly359fs) AND Adams-Oliver syndrome" Accession="RCV000162168" Version="3">
        <ClassifiedConditionList TraitSetID="16878">
          <ClassifiedCondition DB="MedGen" ID="C0265268">Adams-Oliver syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2014-12-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001278689.2(EOGT):c.1074del (p.Gly359fs) AND not provided" Accession="RCV001091100" Version="19">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-04-04" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2015-03-12" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23522784</ID>
        </Citation>
        <DescriptionHistory Dated="2024-04-11">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-05-09">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="16878" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17000" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Adams-Oliver syndrome</ElementValue>
                <XRef ID="MONDO:0007034" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS100300" DB="OMIM" />
                <XRef ID="34748004" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AOS</ElementValue>
                <XRef Type="MIM" ID="100300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5739" />
                <XRef ID="5739" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Adams-Oliver syndrome (AOS) is characterized by aplasia cutis congenita (ACC) of the scalp and terminal transverse limb defects (TTLD). ACC lesions usually occur in the midline of the parietal or occipital regions, but can also occur on the abdomen or limbs. At birth, an ACC lesion may already have the appearance of a healed scar. ACC lesions less than 5 cm often involve only the skin and almost always heal over a period of months; larger lesions are more likely to involve the skull and possibly the dura, and are at greater risk for complications, which can include infection, hemorrhage, or thrombosis, and can result in death. The limb defects range from mild (unilateral or bilateral short distal phalanges) to severe (complete absence of all toes or fingers, feet or hands, or more, often resembling an amputation). The lower extremities are almost always more severely affected than the upper extremities. Additional major features frequently include cardiovascular malformations/dysfunction (23%), brain anomalies, and less frequently renal, liver, and eye anomalies.</Attribute>
                <XRef ID="NBK355754" DB="GeneReviews" />
              </AttributeSet>
              <XRef ID="974" DB="Orphanet" />
              <XRef ID="C0265268" DB="MedGen" />
              <XRef ID="MONDO:0007034" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS100300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10612" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17952" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Adams-Oliver syndrome 4</ElementValue>
                <XRef ID="MONDO:0014124" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AOS4</ElementValue>
                <XRef Type="MIM" ID="615297" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Adams-Oliver syndrome (AOS) is characterized by aplasia cutis congenita (ACC) of the scalp and terminal transverse limb defects (TTLD). ACC lesions usually occur in the midline of the parietal or occipital regions, but can also occur on the abdomen or limbs. At birth, an ACC lesion may already have the appearance of a healed scar. ACC lesions less than 5 cm often involve only the skin and almost always heal over a period of months; larger lesions are more likely to involve the skull and possibly the dura, and are at greater risk for complications, which can include infection, hemorrhage, or thrombosis, and can result in death. The limb defects range from mild (unilateral or bilateral short distal phalanges) to severe (complete absence of all toes or fingers, feet or hands, or more, often resembling an amputation). The lower extremities are almost always more severely affected than the upper extremities. Additional major features frequently include cardiovascular malformations/dysfunction (23%), brain anomalies, and less frequently renal, liver, and eye anomalies.</Attribute>
                <XRef ID="NBK355754" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15941" />
                <XRef ID="15941" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="974" DB="Orphanet" />
              <XRef ID="C3809092" DB="MedGen" />
              <XRef ID="MONDO:0014124" DB="MONDO" />
              <XRef Type="MIM" ID="615297" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="383068" SubmissionDate="2014-12-30" DateLastUpdated="2015-03-12" DateCreated="2015-03-12">
        <ClinVarSubmissionID localKey="11DG2119|MedGen:78544" />
        <ClinVarAccession Accession="SCV000196454" DateUpdated="2015-03-12" DateCreated="2015-03-12" Type="SCV" Version="1" SubmitterName="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" OrgID="500184" OrganizationCategory="laboratory" OrgAbbreviation="DGU-KFSHRC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">research</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EOGT" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001278689.1:c.1074delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Adams-Oliver syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0265268" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">25558065</ID>
        </Citation>
      </ClinicalAssertion>
      <ClinicalAssertion ID="130747" SubmissionDate="2020-12-17" DateLastUpdated="2020-12-22" DateCreated="2013-07-04">
        <ClinVarSubmissionID localKey="614789.0002_ADAMS-OLIVER SYNDROME 4" title="EOGT, 1-BP DEL, 1074A_ADAMS-OLIVER SYNDROME 4" />
        <ClinVarAccession Accession="SCV000077495" DateUpdated="2020-12-22" DateCreated="2013-07-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-04-04">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 2.67-year-old Arab boy with Adams-Oliver syndrome (AOS4; 615297), who was born of consanguineous parents, Shaheen et al. (2013) identified homozygosity for a 1-bp deletion (c.1074delA) in the EOGT gene, causing a frameshift that resulted in a premature stop codon (Gly359AspfsTer28). The mutation was not found in 230 Saudi exomes, the 1000 Genomes Project, or the NHLBI Exome Variant Server. In addition to cutis aplasia of the scalp and terminal transverse defects of the toes that were more pronounced on the right, he had a muscular ventricular septal defect and patent ductus arteriosus, which had resolved. Additional features included left temporal and occipital lobe infarcts of presumed prenatal origin, speech and fine motor delays, and umbilical hernia. Shaheen et al. (2013) stated that using the alternatively spliced NCBI version of EOGT (GenBank NM_173654.1), the mutation would be designated 832-791delA.</Attribute>
              <Citation>
                <ID Source="PubMed">23522784</ID>
              </Citation>
              <XRef DB="OMIM" ID="615297" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EOGT" />
          </GeneList>
          <Name>EOGT, 1-BP DEL, 1074A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1074A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614789.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ADAMS-OLIVER SYNDROME 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3950662" SubmissionDate="2021-11-05" DateLastUpdated="2021-11-11" DateCreated="2021-11-11">
        <ClinVarSubmissionID localKey="3-69037454-CT-C" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002012322" DateUpdated="2021-11-11" DateCreated="2021-11-11" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is not observed in the gnomAD v2.1.1 dataset (PM2). The variant has been reported as pathogenic/likely pathogenic without evidence for the classification (ClinVar ID: VCV000523612.1). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001508" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002194" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001159" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001057" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EOGT" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001278689.1:c.1074del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615297" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10606558</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8993000" SubmissionDate="2024-04-05" DateLastUpdated="2024-04-15" DateCreated="2024-04-15">
        <ClinVarSubmissionID localKey="NM_173654.3:c.832-791del|OMIM:615297" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004809444" DateUpdated="2024-04-15" DateCreated="2024-04-15" Type="SCV" Version="1" SubmitterName="Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center" OrgID="508075" OrganizationCategory="other" OrgAbbreviation="CGM_KFSHRC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-04-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_173654.3:c.832-791del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615297" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14359275</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2468554" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-12">
        <ClinVarSubmissionID localKey="101976|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001246955" DateUpdated="2024-07-15" DateCreated="2020-05-12" Type="SCV" Version="23" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-04-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EOGT" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="C" referenceAllele="CT" start="69037454" stop="69037455" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3950662" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001508" MappingRef="HP">
        <MedGen CUI="C2315100" Name="Failure to thrive" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950662" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001057" MappingRef="HP">
        <MedGen CUI="C0282160" Name="Aplasia cutis congenita" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="130747" TraitType="Disease" MappingType="Name" MappingValue="ADAMS-OLIVER SYNDROME 4" MappingRef="Preferred">
        <MedGen CUI="C3809092" Name="Adams-Oliver syndrome 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950662" TraitType="Disease" MappingType="XRef" MappingValue="615297" MappingRef="OMIM">
        <MedGen CUI="C3809092" Name="Adams-Oliver syndrome 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8993000" TraitType="Disease" MappingType="XRef" MappingValue="615297" MappingRef="OMIM">
        <MedGen CUI="C3809092" Name="Adams-Oliver syndrome 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950662" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001159" MappingRef="HP">
        <MedGen CUI="C0039075" Name="Syndactyly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="383068" TraitType="Disease" MappingType="Name" MappingValue="Adams-Oliver syndrome" MappingRef="Preferred">
        <MedGen CUI="C0265268" Name="Adams-Oliver syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950662" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002194" MappingRef="HP">
        <MedGen CUI="C1837658" Name="Delayed gross motor development" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2468554" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2023-03-03">SCV002022184</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

